Atypical epithelial proliferation in fallopian tubes in prophylactic salpingo-oophorectomy specimens from BRCA1 and BRCA2 germline mutation carriers

被引:105
作者
Carcangiu, ML
Radice, P
Manoukian, S
Spatti, G
Gobbo, M
Pensotti, V
Crucianelli, R
Pasini, B
机构
[1] Ist Nazl Tumori, Dept Pathol, I-20133 Milan, Italy
[2] Ist Nazl Tumori, Dept Expt Oncol, I-20133 Milan, Italy
[3] Ist Nazl Tumori, Dept Prevent & Predict Med, I-20133 Milan, Italy
[4] Ist Nazl Tumori, Gynecol Unit, I-20133 Milan, Italy
[5] FIRC, Inst Mol Oncol, Milan, Italy
关键词
BRCA1; prophylactic salpingo-oophorectomy; fallopian tube; atypical hyperplasia; carcinoma in situ;
D O I
10.1097/01.pgp.0000101082.35393.84
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Although growing numbers of tubal carcinomas in carriers of BRCA1 and BRCA2 germline mutations have been reported, very little is known about the nature and frequency of their possible precursor lesions. The aim of this study is to investigate the occurrence of atypical proliferative tubal lesions in grossly normal fallopian tubes from 26 women with BRCA1 and BRCA2 germline mutations who underwent prophylactic salpingo-ooophorectomy and whose ovaries were histologically negative for carcinoma. Fallopian tubes from 49 women who had undergone hysterectomy with salpingo-oophorectomy for uterine leiomyoma served as controls. In the 22 BRCA1-mutated women, there were two in situ carcinomas and two atypical hyperplasias of the tubal epithelium. The tubes of the BRCA2-mutated women and of the 49 control women did not show any atypical proliferation. The frequency of proliferative lesions of the tubal epithelium, including in situ carcinoma, appears to be increased in BRCA1 mutation carriers. Removal and thorough examination of the fallopian tubes at the time of surgical prophylaxis for ovarian cancer is therefore recommended.
引用
收藏
页码:35 / 40
页数:6
相关论文
共 37 条
[1]   Unexpected gynecologic neoplasms in patients with proven or suspected BRCA-1 or-2 mutations - Implications for gross examination, cytology, and clinical follow-up [J].
Agoff, SN ;
Mendelin, JE ;
Grieco, VS ;
Garcia, RL .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2002, 26 (02) :171-178
[2]   A genetic epidemiological study of carcinoma of the fallopian tube [J].
Aziz, S ;
Kuperstein, G ;
Rosen, B ;
Cole, D ;
Nedelcu, R ;
McLaughlin, J ;
Narod, SA .
GYNECOLOGIC ONCOLOGY, 2001, 80 (03) :341-345
[3]   PRIMARY ADENOCARCINOMA OF THE FALLOPIAN-TUBE - REVIEW OF THE LITERATURE [J].
BAEKELANDT, M ;
KOCKX, M ;
WESLING, F ;
GERRIS, J .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1993, 3 (02) :65-71
[4]  
Barakat RR, 2000, CANCER, V89, P383, DOI 10.1002/1097-0142(20000715)89:2<383::AID-CNCR25>3.0.CO
[5]  
2-T
[6]  
Carcangiu M. L., 2003, Modern Pathology, V16, p184A
[7]   PSEUDOCARCINOMATOUS HYPERPLASIA OF THE FALLOPIAN-TUBE ASSOCIATED WITH SALPINGITIS - A REPORT OF 14 CASES [J].
CHEUNG, ANY ;
YOUNG, RH ;
SCULLY, RE .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1994, 18 (11) :1125-1130
[8]   Overexpression of p53 and HER-2/neu and c-myc in primary fallopian tube carcinoma [J].
Chung, TKH ;
Cheung, TH ;
To, KF ;
Wong, YF .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2000, 49 (01) :47-51
[9]  
CLEMENT PB, 2000, ATLAS GYNECOLOGYC SU
[10]   Occult carcinoma in prophylactic oophorectomy specimens - Prevalence and association with BRCA germline mutation status [J].
Colgan, TJ ;
Murphy, J ;
Cole, DEC ;
Narod, S ;
Rosen, B .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (10) :1283-1289